Oral EPI-7386 in patients with metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Pachynski, Russell Kent
Iannotti, Nicholas
Laccetti, Andrew Leonard
Carthon, Bradley Curtis
Chi, Kim N.
Smith, Matthew Raymond
Vogelzang, Nicholas J.
Tu, Wilson
Kwan, Edmond Michael
Wyatt, Alexander William
Villaluna, Karen
Younginger, Brett
Cesano, Alessandra
机构：
[1] Washington Univ Sch Med, St Louis, MO USA
[2] Treasure Coast, Hematol Oncol Assoc, Port St Lucie, FL USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[5] Vancouver Ctr, BC Canc, Vancouver, BC, Canada
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[8] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[9] Essa Pharmaceut, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
177
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer
    Burgio, Salvatore L.
    Conteduca, Vincenza
    Rudnas, Britt
    Carrozza, Francesco
    Campadelli, Enrico
    Bianchi, Emanuela
    Fabbri, Paolo
    Montanari, Marco
    Carretta, Elisa
    Menna, Cecilia
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 39 - 43
  • [32] Evolution of the Treatment Paradigm for Patients with Metastatic Castration-Resistant Prostate Cancer
    Zafar Malik
    Heather Payne
    Jawaher Ansari
    Simon Chowdhury
    Mohammad Butt
    Alison Birtle
    Santhanam Sundar
    Chinnamani Vee Eswar
    Simon Hughes
    Amit Bahl
    Advances in Therapy, 2013, 30 : 1041 - 1066
  • [33] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [34] New treatment options for patients with metastatic castration-resistant prostate cancer
    Higano, Celestia S.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 340 - 345
  • [35] Chemotherapy in frail elderly patients with metastatic castration-resistant prostate cancer?
    Molina-Garrido, Maria-Jose
    Guillen-Ponce, Carmen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 579 - 580
  • [36] Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer
    J. Wang
    T. R. McGuire
    H. C. Britton
    J. K. Schwarz
    F. R. Loberiza
    J. L. Meza
    J. E. Talmadge
    Clinical & Experimental Metastasis, 2015, 32 : 111 - 124
  • [37] Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
    Markova, A. S.
    Polikarpova, S. B.
    Kamolov, B. Sh.
    Gridneva, Ya. V.
    Kalinin, S. A.
    Peters, M. V.
    Matveev, V. B.
    ONKOUROLOGIYA, 2015, 11 (02): : 77 - 84
  • [38] Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer
    Wang, J.
    McGuire, T. R.
    Britton, H. C.
    Schwarz, J. K.
    Loberiza, F. R., Jr.
    Meza, J. L.
    Talmadge, J. E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (02) : 111 - 124
  • [39] Circadian gene expression in metastatic sites and association with survival in metastatic castration-resistant prostate cancer.
    Booker, Benjamin D.
    Stopsack, Konrad H.
    Gerke, Travis A.
    Penny, Kathryn
    Kantoff, Philip W.
    Mucci, Lorelei A.
    Markt, Sarah C.
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Evolution of the Treatment Paradigm for Patients with Metastatic Castration-Resistant Prostate Cancer
    Malik, Zafar
    Payne, Heather
    Ansari, Jawaher
    Chowdhury, Simon
    Butt, Mohammad
    Birtle, Alison
    Sundar, Santhanam
    Eswar, Chinnamani Vee
    Hughes, Simon
    Bahl, Amit
    ADVANCES IN THERAPY, 2013, 30 (12) : 1041 - 1066
12345